Patrys Ltd has released a press release.
Patrys Successfully Establishes PAT-DX1 Stable Cell Line
Filed with ASX ·
6ix hasn’t read this filing yet.
Earlier from Patrys
- Appendix 4C - Quarterly - 31 December 2020
- $7.3M Capital Raising
- Investor Presentation - November 2020 - Updated
- Investor Presentation - November 2020
- Appendix 4C - Quarterly - 30 September 2020
Later from Patrys
- Appendix 4D - Half Year Accounts - 31 December 2020
- New United States patent granted for Patrys deoxymab assets
- Appendix 4C - Quarterly - 31 March 2021
- Patrys receives R&D Tax Incentive refund
- Paper highlights PAT-DX1 as potential brain cancer treatment
Follow Patrys into a list and get an email when it puts out news.
Follow Patrys